What is Global BCG Vaccine for Tuberculosis (TB) Market?
The Global BCG Vaccine for Tuberculosis (TB) Market refers to the worldwide industry focused on the production, distribution, and sale of the Bacillus Calmette-Guérin (BCG) vaccine, which is primarily used to prevent tuberculosis (TB).

Immune Type, Therapy Type in the Global BCG Vaccine for Tuberculosis (TB) Market:
TB is a contagious infection that primarily affects the lungs but can also impact other parts of the body.
Hospitals, Clinics, Others in the Global BCG Vaccine for Tuberculosis (TB) Market:
The BCG vaccine, developed in the early 20th century, is one of the oldest vaccines still in use today and is particularly effective in preventing severe forms of TB in children.
Global BCG Vaccine for Tuberculosis (TB) Market Outlook:
The global market for this vaccine is driven by the high prevalence of TB in various regions, especially in developing countries where the disease remains a significant public health challenge.
Report Metric | Details |
Report Name | BCG Vaccine for Tuberculosis (TB) Market |
Accounted market size in year | US$ 80.4 million |
Forecasted market size in 2031 | US$ 99 million |
CAGR | 3.1% |
Base Year | year |
Forecasted years | 2025 - 2031 |
Segment by Type |
|
Segment by Application |
|
Consumption by Region |
|
By Company | Merck, Japan BCG Lab, China National Biotec, AJ Vaccines, Serum Institute of India, BioFarma, GSBPL, Biomed Lublin, Taj Pharmaceuticals, Ataulpho de Paiva, ANLIS Malbran, Fundação Ataulpho de Paiva, BB-NCIPD, Torlakinstitut, IVAC – Institute of Vaccines and Medical Biologicals, Institut Pasteur de Tunis |
Forecast units | USD million in value |
Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |